Trump Intensifies Pressure on Bank of America and JPMorgan Over Alleged AntiConservative Banking Practices
Feds Powell Vows No Shadow Chair Role but Warsh Dynamics May Complicate Meetings
Powell to Step Down as Fed Chair but Remain on Board Signaling Policy Continuity
Berkshire Hathaway Boosts Alphabet Stake Initiates Delta Air Lines Position
SP 500 Rises on Tech and Healthcare Strength Communication Services Lags
Kevin Warsh Takes Helm as Fed Chair Amid Trumps Push for Rate Cuts Markets Expect Extended Pause
Autoliv Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher
High Tide Inc Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains
CURB Q1 2026 Earnings EPS Misses Estimates but Stock Moves Higher
Fluence Energy Q1 2026 Earnings NarrowerThanExpected Loss Stock Declines
HeartSciences Inc HSCS Q1 2026 Earnings WiderThanExpected Loss Narrows on Strong Cost Control Shares Rally
SEE Q4 2025 Earnings EPS Surpasses Estimates by 43 Revenue Details Remain Undisclosed
Zevra Therapeutics ZVRA Sheds Over 4 as Stock Tests Key Support Levels
NICE Ltd NICE Faces Pressure Support Levels Tested After 219 Decline
Skye Bioscience Surges 77 Biotech Stock Tests Resistance at 081
Smithfield Foods Inc SFD Gains Ground Approaches Key Resistance
Plum Acquisition Corp IV Warrants PLMKW Hold Steady at 060 as Trading Consolidates
AEM Holdings CEO AI Demand Becomes as Essential as Water and Power as Shares Surge 450
RxSight Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Data Unavailable
StableX Technologies Holds Steady Near Key Levels as SBLX Consolidates
Sunstone Hotel Investors SHO Rises Modestly Tests Key Resistance Near 1125
Brighthouse Financial Preferred BHFAP Holds Steady Near Range Midpoint Amid Low Volatility
Citizens Northern Corp CZNC Holds Steady Near Support Level Amid Low Volatility
Lionheart Holdings CUB Holds Steady at 1080 as Stock Trades Flat
T Stamp Inc IDAI Surges 7 as Biometric Identity Stock Breaks Above Key Support Level
Jack In The Box JACK Edges Higher as Stock Tests Key Resistance Level
Hoth Therapeutics Holds Steady at 136 as Stock Consolidates Near Support